| CCNB2 |
CCNB2: G2/mitotic-specific cyclin-B2 |
CDKN1B |
CDKN1B, KIP1: Cyclin-dependent kinase inhibitor 1B |
1.432 |
Evidence |
|
| MTA2 |
MTA1L1, MTA2, PID: Metastasis-associated protein MTA2 |
HDAC2 |
HDAC2: Histone deacetylase 2 |
1.432 |
Evidence |
|
| ZFHX1B |
Zinc finger homeobox protein 1b |
MLLT7 |
IPI00654651 |
1.432 |
Evidence |
|
| ZFHX1B |
Zinc finger homeobox protein 1b |
LEF1 |
LEF1: Lymphoid enhancer-binding factor 1 |
1.432 |
Evidence |
|
| ZFHX1B |
Zinc finger homeobox protein 1b |
FOXO1A |
FOXO1A, FKHR: Forkhead box protein O1A |
1.432 |
Evidence |
|
| GALR2 |
GALR2, GALNR2: Galanin receptor type 2 |
HTR2A |
HTR2A, HTR2: 5-hydroxytryptamine receptor 2A |
1.432 |
Evidence |
|
| PLD2 |
PLD2: Phospholipase D2 |
PRKCH |
PRKCH, PKCL, PRKCL: Protein kinase C eta type |
1.432 |
Evidence |
|
| APS |
SH2B2, APS: SH2B adapter protein 2 |
SOCS2 |
SOCS2, CIS2, SSI2, STATI2: Suppressor of cytokine signaling 2 |
1.432 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
TRIB2 |
TRIB2, TRB2: Tribbles homolog 2 |
1.432 |
Evidence |
|
| RFC5 |
RFC5: Replication factor C subunit 5 |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
1.427 |
Evidence |
|
| RFC4 |
RFC4: Replication factor C subunit 4 |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
1.427 |
Evidence |
O
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
CD40LG |
CD40LG, CD40L, TNFSF5, TRAP: CD40 ligand |
1.427 |
Evidence |
|
| RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
ARHGDIB |
ARHGDIB, GDIA2, GDID4, RAP1GN1: Rho GDP-dissociation inhibitor 2 |
1.427 |
Evidence |
O
|
| RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
1.427 |
Evidence |
|
| RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
VAV1 |
VAV1, VAV: Proto-oncogene vav |
1.427 |
Evidence |
|
| DCP1B |
DCP1B: mRNA-decapping enzyme 1B |
EIF2C4 |
EIF2C4, AGO4, KIAA1567: Eukaryotic translation initiation factor 2C 4 |
1.427 |
Evidence |
|
| NOS2A |
NOS2A, NOS2: Nitric oxide synthase, inducible |
DLG1 |
IPI00218729 |
1.427 |
Evidence |
|
| FGFR2 |
IPI00218422 |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
1.427 |
Evidence |
|
| HMOX1 |
HMOX1, HO, HO1: Heme oxygenase 1 |
GIT2 |
IPI00238218 |
1.427 |
Evidence |
|
| GOT2 |
GOT2: Aspartate aminotransferase, mitochondrial precursor |
CFL2 |
CFL2: Cofilin-2 |
1.427 |
Evidence |
|
| CTSL2 |
CTSL2, CATL2, UNQ268/PRO305, CTSU, CTSV: Cathepsin L2 precursor |
ATP1A1 |
ATP1A1: Sodium/potassium-transporting ATPase subunit alpha-1 precursor |
1.427 |
Evidence |
|
| TNFRSF11B |
TNFRSF11B, OCIF, OPG: Tumor necrosis factor receptor superfamily member 11B prec |
TNFRSF10C |
TNFRSF10C, DCR1, UNQ321/PRO366, LIT, TRAILR3, TRID: Tumor necrosis factor recept |
1.425 |
Evidence |
|
| PSMD1 |
PSMD1: 26S proteasome non-ATPase regulatory subunit 1 |
PCDHGB4 |
IPI00028619 |
1.425 |
Evidence |
|
| RGS4 |
RGS4: Regulator of G-protein signaling 4 |
HRH4 |
HRH4, GPCR105: Histamine H4 receptor |
1.425 |
Evidence |
|
| MTNR1A |
MTNR1A: Melatonin receptor type 1A |
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
1.425 |
Evidence |
|